Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$3.18 - $6.86 $8,194 - $17,678
2,577 Added 2.47%
106,977 $722,000
Q3 2023

Nov 13, 2023

BUY
$3.25 - $6.08 $339,300 - $634,752
104,400 New
104,400 $463,000
Q4 2021

Feb 14, 2022

SELL
$14.0 - $28.44 $275,800 - $560,268
-19,700 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$7.28 - $30.97 $143,416 - $610,109
19,700 New
19,700 $556,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $227M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.